Granted Approval to Open the State’s First Medical Marijuana
Dispensary
WINTERSVILLE, Ohio--(BUSINESS WIRE)--
Cresco
Labs (CSE:CL), one of the largest vertically integrated multistate
cannabis operators in the United States, today announced that it has
been granted the first approval to operate a marijuana dispensary in the
state of Ohio. The new facility located in the village of Wintersville,
named CY+ (pronounced “see why plus”), will offer a wide selection of
pharmaceutical-grade cannabis for physician-certified patients across
Ohio.
“Receiving the first approval to operate is a major milestone in the
transformation of the cannabis program in Ohio,” said Charles Bachtell,
CEO of Cresco Labs. “This is also a big step forward for Cresco along
our path of unparalleled speed to market, powerful influence in industry
development, and proven execution in consumer markets.”
The CY+ dispensary will offer a full selection of premium-quality
medical marijuana for patients who have been physician-certified to have
any one of 21 approved medical conditions. In addition to the dispensary
in Wintersville, Cresco Labs has built an environmentally-advanced
50,000 square foot growing and cultivation facility in Yellow Springs,
Ohio which will supply statewide dispensaries with Cresco’s full suite
of branded products.
“At Cresco, we pride ourselves on understanding the individual needs of
each and every one of our patients. Our Wintersville staff is trained by
leading cannabis doctors and researchers across the country to ensure
that our patients’ specific needs are consistently met. In Wintersville
we will continue to advance our mission of normalizing and
professionalizing the cannabis industry for consumers,” Bachtell added.
The Wintersville dispensary features private, one-on-one consultation
areas where patients can feel comfortable discussing their conditions or
symptoms and exploring the appropriate medical marijuana products.
Products offered will range from edibles, vape pens and cartridges to
oral sprays, pills, and transdermal patches. Video footage of the new
dispensary can be downloaded and viewed here.
About Cresco Labs:
Cresco Labs, based in Chicago, is a leading U.S. cannabis company with
experienced management, access to capital and a demonstrated growth
strategy. As a differentiated grower, processor and retailer of premium
cannabis operating in seven states, the company focuses on entering
highly regulated markets with outsized demand potential and high
barriers to entry. Its impressive speed-to-market gives Cresco a
distinct competitive advantage as it replicates its model to expand its
national footprint. Cresco’s proven ability to execute is complemented
by a cutting-edge brand strategy spearheaded by several of the brightest
minds in consumer marketing in the nation. Cresco’s products are
tailored to all major consumer segments: everyday cannabis, medicinally
focused, connoisseur grade, and chef inspired edibles by James Beard
Award-winning pastry chef Mindy Segal. Learn more about Cresco Labs at crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the
meaning of applicable Canadian securities legislation and may also
contain statements that may constitute "forward-looking statements"
within the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Such forward-looking
information and forward-looking statements are not representative of
historical facts or information or current condition, but instead
represent only the Company's beliefs regarding future events, plans or
objectives, many of which, by their nature, are inherently uncertain and
outside of the Company's control. Generally, such forward-looking
information or forward-looking statements can be identified by the use
of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’
‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’
‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the
negative of those forms or other comparable terms. The Company’s
forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the Company’s actual
results, performance or achievements to be materially different from any
future results, performance or achievements expressed or implied by the
forward-looking statements, including but not limited to those risks
discussed under "Risk Factors" in the company’s CSE Listing Statement
filed with SEDAR; and other factors, many of which are beyond the
control of the Company. Readers are cautioned that the foregoing list of
factors is not exhaustive. Because of these uncertainties, you should
not place undue reliance on the Company’s forward-looking statements. No
assurances are given as to the future trading price or trading volumes
of Cresco’s shares, nor as to the Company’s financial performance in
future financial periods. The Company does not intend to update any of
these factors or to publicly announce the result of any revisions to any
of the Company’s forward-looking statements contained herein, whether as
a result of new information, any future event or otherwise. Except as
otherwise indicated, this press release speaks as of the date hereof.
The distribution of this press release does not imply that there has
been no change in the affairs of the Company after the date hereof or
create any duty or commitment to update or supplement any information
provided in this press release or otherwise.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20181212005867/en/
Cresco Labs:
Jason Erkes
Chief Communications Officer
312.953.2767
je@crescolabs.com
Source: Cresco Labs